Serelaxin treatment does not reduce incidence of death in patients with AHF
Abstract
In patients with acute heart failure, treatment with serelaxin, a recombinant form of human relaxin 2, did not reduce the incidence of cardiovascular death or worsening heart...
Paper Details
Title
Serelaxin treatment does not reduce incidence of death in patients with AHF
Published Date
Sep 2, 2019
Journal
Volume
16
Issue
11
Pages
649 - 649
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History